Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial

BACKGROUND: Currently, endovascular treatment is indicated to treat femoropopliteal lesions ≤15 cm. However, the Achilles’ heel of femoropopliteal endovascular repair remains restenosis. Paclitaxel eluting stents have shown promising results to prevent restenosis in femoropopliteal lesions compared...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Trials
Asıl Yazarlar: Gouëffic, Yann, Kaladji, Adrien, Guyomarch, Béatrice, Montagne, Carine, Fairier, Damien, Gestin, Simon, Riche, Valéry-Pierre, Vent, Pierre Alexandre, Chaillou, Philippe, Costargent, Alain, Patra, Philippe
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Study Protocol
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226912/
https://ncbi.nlm.nih.gov/pubmed/25359394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-423
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller